CAI (STOCKS)
Caris Life Sciences, Inc. Common Stock
$18.180000
+0.210000 (+1.17%)
Prev close: $17.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David Dean Halbert
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,141.96M
- Employees
- 1,846
- P/E (TTM)
- -12.26
- P/B (TTM)
- 8.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.00 | $-0.02 | +0.0221 | +100.00% |
|
Dec 2025 (Q4)
|
$0.28 | $0.03 | +0.2481 | +777.74% |
|
Sep 2025 (Q3)
|
$0.08 | $-0.21 | +0.2941 | +138.66% |
|
Jun 2025 (Q2)
|
$-7.97 | $-0.20 | -7.7680 | -3,845.54% |
Financial Statements
| Revenues | $907.29M |
| Benefits Costs and Expenses | $873.44M |
| Costs And Expenses | $798.95M |
| Nonoperating Income/Loss | -$74.50M |
| Operating Expenses | $798.95M |
| Research and Development | $109.83M |
| Other Operating Expenses | $689.11M |
| Operating Income/Loss | $108.35M |
| Income/Loss From Continuing Operations After Tax | $33.98M |
| Income/Loss From Continuing Operations Before Tax | $33.85M |
| Income Tax Expense/Benefit | -$134.00K |
| Net Income/Loss | $33.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $33.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$411.43M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $445.41M |
| Preferred Stock Dividends And Other Adjustments | $445.41M |
| Basic Earnings Per Share | -$6.27 |
| Diluted Earnings Per Share | -$6.28 |
| Basic Average Shares | 668,338,017 |
| Diluted Average Shares | 683,450,782 |
| Assets | $1.16B |
| Current Assets | $1.01B |
| Prepaid Expenses | $19.62M |
| Other Current Assets | $994.56M |
| Noncurrent Assets | $148.21M |
| Fixed Assets | $82.67M |
| Other Non-current Assets | $65.54M |
| Liabilities | $568.90M |
| Current Liabilities | $143.90M |
| Accounts Payable | $69.80M |
| Other Current Liabilities | $74.09M |
| Noncurrent Liabilities | $425.00M |
| Long-term Debt | $381.07M |
| Other Non-current Liabilities | $43.93M |
| Equity | $593.49M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $593.49M |
| Liabilities And Equity | $1.16B |
| Net Cash Flow From Operating Activities | $147.37M |
| Net Cash Flow From Operating Activities, Continuing | $147.37M |
| Net Cash Flow From Investing Activities | -$23.91M |
| Net Cash Flow From Investing Activities, Continuing | -$23.91M |
| Net Cash Flow From Financing Activities | $664.53M |
| Net Cash Flow From Financing Activities, Continuing | $664.53M |
| Net Cash Flow | $787.98M |
| Net Cash Flow, Continuing | $787.98M |
| Comprehensive Income/Loss | $34.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $34.63M |
| Other Comprehensive Income/Loss | $34.63M |
| Other Comprehensive Income/Loss Attributable To Parent | $633.00K |